| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01598561d1bcf6cb9d0f4b0cfd7f3ade
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe15c8db966260183711d719d4b06a03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cf7f3f36d20185ce15a2d1f04d5fdc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa6a514d926365bc51c09047b432f30b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9c9bec18ba27b7ba42c0ec4fc3d34e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab076dbaa11ba7c868d14dcc15765a6a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 |
| filingDate |
2009-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91d1dc35150fa0361749347f4d8f3fdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_916261a68b874d94effc04a8869358a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ff2d50c63033978bcf362173bba52cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a32ec5fc502b1f0819feab2c36a7cba2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c64dda27776eb7e891ea7054b478cf49 |
| publicationDate |
2010-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010000740-A1 |
| titleOfInvention |
Pharmaceutical dosage form comprising polymeric carrier composition |
| abstract |
A pharmaceutical dosage form comprises a solid dispersion product of at least one active ingredient dispersed in a polymeric binder composition, the polymeric carrier composition comprising a) a vinylpyrrolidone homopolymer, wherein at least 95 % by weight of the vinylpyrrolidone homopolymer has a molecular weight distribution within the range of from 1000 to 13 000; and b) a vinylpyrrolidone copolymer having a weight- average molecular weight of from 5000 to 1 500 000. The dosage form is preferably prepared by a melt extrusion process. The polymeric carrier composition exhibits a high drug dissolution power and allows a reduction of the viscosity of the melt without deteriorating the mechanical properties and storage stability of the dosage form. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012085236-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014296336-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463739-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014500299-A |
| priorityDate |
2008-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |